|  | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
 |  | 30-days mortality (%) | P value | Odds ratio (95% CI) | P value |
Group | A | 51.7 | 0.001 | Ref. | 0.014 |
 | B | 16.1 |  | 0.080 (0.011–0.605) |  |
Background factors | |||||
Age | < 65 years | 33.3 | 0.583 |  |  |
 | ≥ 65 years | 26.6 |  |  |  |
Gender | Female | 31.4 | 0.630 | Â | Â |
 | Male | 26.0 |  |  |  |
Type | EAMI | 22.2 | 0.292 | Â | Â |
 | TAMI | 25.9 |  |  |  |
 | NOMI | 37.1 |  |  |  |
 | VAMI | 0.0 |  |  |  |
Medical history | |||||
Recent cardiovascular procedurea | No | 21.2 | 0.018 | Ref. | 0.326 |
 | Yes | 52.6 |  | 2.765 (0.364–21.028) |  |
Coronary artery disease | No | 30.8 | 0.624 | Â | Â |
 | Yes | 24.2 |  |  |  |
Cerebral vascular event | No | 27.5 | 0.765 | Â | Â |
 | Yes | 31.3 |  |  |  |
Chronic lung disease | No | 28.4 | 1.000 | Â | Â |
 | Yes | 27.3 |  |  |  |
Essential hypertension | No | 20.8 | 0.428 | Â | Â |
 | Yes | 31.1 |  |  |  |
Dyslipidemia | No | 29.1 | 0.671 | Â | Â |
 | Yes | 16.7 |  |  |  |
Liver cirrhosis | No | 29.1 | 0.671 | Â | Â |
 | Yes | 16.1 |  |  |  |
Atrial fibrillation | No | 27.4 | 0.733 | Â | Â |
 | Yes | 33.3 |  |  |  |
Diabetes mellitus | No | 21.6 | 0.139 | Â | Â |
 | Yes | 38.2 |  |  |  |
Dialysis | No | 26.6 | 0.583 | Â | Â |
 | Yes | 33.3 |  |  |  |
Regular antiplatelet or anticoagulant use (n) | No | 23.1 | 0.221 | Â | Â |
 | Yes | 36.4 |  |  |  |
Preoperative factors | |||||
WBC count out of normal rangeb | No | 24.3 | 0.628 | Â | Â |
 | Yes | 31.3 |  |  |  |
Positive band form of WBC | No | 18.4 | 0.092 | Ref. | 0.430 |
 | Yes | 36.2 |  | 0.487 (0.081–2.912) |  |
NLR | < 23.8 | 27.0 | 0.784 |  |  |
 | ≥ 23.8 | 31.8 |  |  |  |
Platelet count | ≥ 100,000/uL | 16.9 | 0.001 | Ref. | 0.031 |
 | < 100,000/uL | 53.8 |  | 10.293 (1.231–86.086) |  |
INR of PT | ≤ 1.7 | 24.3 | 0.067 | Ref. | 0.976 |
 | > 1.7 | 54.5 |  | 0.959 (0.063–14.503) |  |
Hemoglobin | ≥ 12 g/dL | 24.2 | 0.624 |  |  |
 | < 12 g/dL | 30.8 |  |  |  |
Serum albumin | ≥ 2.8 g/dL | 16.7 | 0.008 | Ref. | 0.406 |
 | < 2.8 g/dL | 43.2 |  | 2.003 (0.389–10.314) |  |
Serum ALT | < 100 U/L | 17.9 | 0.000 | Ref. | 0.029 |
 | ≥ 100 U/L | 66.7 |  | 11.523 (1.283–103.481) |  |
Serum bilirubin | < 2.0 mg/dL | 24.2 | 0.153 |  |  |
 | ≥ 2.0 mg/dL | 42.1 |  |  |  |
Serum creatinine | < 2.0 mg/dL | 11.1 | 0.020 | Ref. | 0.716 |
 | ≥ 2.0 mg/dL | 36.2 |  | 1.407 (0.223–8.868) |  |
Shock status | No | 12.5 | 0.000 | Ref. | 0.153 |
 | Yes | 58.6 |  | 3.438 (0.631–18.723) |  |
Surgical factors | |||||
Time to surgeryc | < 12 h | 30.3 | 0.567 |  |  |
 | ≥ 12 h | 21.1 |  |  |  |
Intraoperative red blood transfusion | No | 28.9 | 1.000 | Â | Â |
 | Yes | 22.2 |  |  |  |
Combined colon resection | No | 25.4 | 0.438 | Â | Â |
 | Yes | 34.6 |  |  |  |
End-enterostomy | No | 16.0 | 0.122 | Â | Â |
 | Yes | 33.3 |  |  |  |
Functional residual small intestine | ≥ 100 cm | 22.4 | 0.224 |  |  |
 | < 100 cm | 36.1 |  |  |  |
Postoperative medical factor | |||||
Oral antiplatelets | No | 39.0 | 0.001 | Ref. | 0.018 |
 | Yes | 3.8 |  | 0.025 (0.001–0.528) |  |